Inflammatory Bowel Disease Treatment Market Outlook and Strategic Insights by 2031

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2031

Inflammatory Bowel Disease Treatment Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class (Biologics, Aminosalicyclates, Corticosteroids, and Others), Disease Indication (Crohn's Disease and Ulcerative Colitis), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Geography

  • Report Date : Aug 2025
  • Report Code : TIPRE00003491
  • Category : Life Sciences
  • Status : Data Released
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150

The inflammatory bowel disease treatment market value is projected to grow from US$ 24.05 billion in 2023 to US$ 31.67 billion by 2031; the market is anticipated to record a CAGR of 3.50% from 2023 to 2031.

Market Insights and Analyst View:

Inflammatory bowel disease (IBD) is a chronic inflammatory condition of the gastrointestinal tract, including Crohn's disease and ulcerative colitis. These conditions cause inflammation of the digestive tract lining, leading to symptoms like abdominal pain, diarrhea, fatigue, and weight loss. Treatment aims to reduce inflammation, manage symptoms, and prevent complications through medication, lifestyle changes, and sometimes surgery. Managing IBD typically requires ongoing medical care and monitoring to maintain remission and improve quality of life. The key factors driving the Inflammatory Bowel Disease Treatment Market growth are the rising prevalence of Crohn's disease and ulcerative colitis, and the increasing number of product launches. This report includes growth prospects owing to the current Inflammatory Bowel Disease Treatment Market trends and their foreseeable impact during the forecast period. Technological advancements are likely to bring significant trends in the Inflammatory Bowel Disease Treatment Market in the coming years. Further, the development of innovative treatments through continuing research as well as encouraging government initiatives are also expected to fuel the market growth.

Growth Drivers and Challenges:

Crohn’s disease is a complex, chronic disorder that primarily affects the digestive system. The National Library of Medicine stated that there were 825 cases of IBD per 100,000 people in 2023, including compared to 410 cases of Crohn's disease and 414 cases of ulcerative colitis and IBD-u. With a prevalence of 0.82%, 322,600 Canadians were had IBD in 2023. Patients with gastrointestinal disease are at an increased risk of nutritional deterioration due to fasting requirements of diagnostic tests, therapeutic dietary restrictions, and loss of appetite due to anorexia or altered nutritional requirements caused due to the disease itself. Thus, enteral nutrition is prescribed for gastrointestinal disease patients, as the enteral route is preferred to provide the required nutrients. Therefore, the rising prevalence of Crohn’s disease and ulcerative colitis drives the growth of the Inflammatory Bowel Disease Treatment Market.

Crohn’s disease, gastrointestinal disease due to trauma, bowel obstruction (BO), microscopic colitis, short bowel syndrome, and ulcerative colitis are a few of the common gastrointestinal diseases. According to an article published in Healthline in 2021, ~40% of people across the world were affected by functional gastrointestinal disorders. The Canadian Digestive Health Foundation states millions of Canadians live with digestive diseases; ~20 million Canadians, i.e., 2 of every 3 people, suffer from digestive disorders yearly.

On the other hand, the high cost associated with treating inflammatory bowel disease (IBD) is a significant barrier in the IBD treatment market. From expensive medications to frequent hospitalizations and surgeries, managing IBD can place a heavy financial burden on patients and healthcare systems. The cost factor often limits access to optimal care and innovative treatments for many individuals living with IBD. Addressing the affordability and accessibility issues is crucial for improving outcomes and quality of life for patients affected by this chronic condition. Thus, the high cost associated with treatment hinders the Inflammatory Bowel Disease Treatment Market growth.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Inflammatory Bowel Disease Treatment Market: Strategic Insights

inflammatory-bowel-disease-treatment-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Report Segmentation and Scope:

The Inflammatory Bowel Disease Treatment Market analysis has been carried out by considering the following segments: drug class, disease indication, and distribution channel. Based on geography, the Inflammatory Bowel Disease Treatment Market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

Segmental Analysis:

Drug Class-Based Insights

Based on drug class, the market is segmented into biologics, aminosalicyclates, corticosteroids, and others. The biologics segment held the largest Inflammatory Bowel Disease Treatment Market share in 2023, and it is anticipated to register the highest CAGR during 2023–2031.

Disease Indication-Based Insights

Based on disease indication, the Inflammatory Bowel Disease Treatment Market is bifurcated into Crohn's disease and ulcerative colitis. The Crohn's disease segment is anticipated to hold a significant market share by 2031.

Disease Indication-Based Insights

Based on distribution channel, the market is classified hospital pharmacy, retail pharmacy, and online pharmacy. The hospital pharmacy segment is anticipated to hold a significant Inflammatory Bowel Disease Treatment Market share by 2031.

Inflammatory Bowel Disease Treatment Market Regional Insights

The regional trends and factors influencing the Inflammatory Bowel Disease Treatment Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Inflammatory Bowel Disease Treatment Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

inflammatory-bowel-disease-treatment-market-global-geography
  • Get the Regional Specific Data for Inflammatory Bowel Disease Treatment Market

Inflammatory Bowel Disease Treatment Market Report Scope

Report Attribute Details
Market size in 2023 US$ 24.05 Billion
Market Size by 2031 US$ 31.67 Billion
Global CAGR (2023 - 2031) 3.50%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Drug Class
  • Aminosalicyclates
  • Immunomodulators
  • TNF Inhibitors
  • Corticosteroids
By Indication
  • Crohn's Disease
  • Ulcerative Colitis
By Distribution Channel
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Pfizer, Inc.,
  • Novartis AG,
  • AbbVie, Inc.,
  • Takeda Pharmaceuticals, Johnson and Johnson
  • , Celegene Corporation,
  • Bausch Health Companies
  • , UCB, Inc.
  • Cosmo Pharmaceutic``als

  • Inflammatory Bowel Disease Treatment Market Players Density: Understanding Its Impact on Business Dynamics

    The Inflammatory Bowel Disease Treatment Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

    Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

    Major Companies operating in the Inflammatory Bowel Disease Treatment Market are:

    1. Pfizer, Inc.,
    2. Novartis AG,
    3. AbbVie, Inc.,
    4. Takeda Pharmaceuticals, Johnson and Johnson
    5. , Celegene Corporation,
    6. Bausch Health Companies

    Disclaimer: The companies listed above are not ranked in any particular order.


    inflammatory-bowel-disease-treatment-market-cagr

    • Get the Inflammatory Bowel Disease Treatment Market top key players overview

    Regional Analysis:

    The geographic scope of the Inflammatory Bowel Disease Treatment Market report encompasses North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. In 2023, North America held the largest market share. Th US dominates the market in North America with the largest revenue share. The expanding Inflammatory Bowel Disease Treatment Market size in this country is attributed to an upsurge in the prevalence of inflammatory diseases, the presence of major market players and their strategic initiatives. Improved payment solutions, high treatment rates, rising prescription of innovative medications, uninterrupted research efforts, and favorable government initiatives also benefit the Inflammatory Bowel Disease Treatment Market in the US and other North American countries. Crohn's & Colitis Foundation is one of the noteworthy organizations dedicated to promoting clinical and translational research aimed at curing colitis and Crohn's disease.

    Competitive Landscape and Key Companies:

    The Inflammatory Bowel Disease Treatment Market forecast presented in this report can help stakeholders in this marketplace plan their growth strategies. AbbVie Inc, Takeda Pharmaceutical Company Limited, Pfizer Inc, Biogen, Novartis AG, Lilly, UCB S.A., CELLTRION INC., Merck & Co., Inc., and Johnson & Johnson Services, Inc. are a few key companies profiled in the Inflammatory Bowel Disease Treatment Market report. These companies focus on expanding their offerings to meet the growing consumer demand worldwide. Their global presence allows them to serve many customers, subsequently allowing them to expand their market presence.


    Frequently Asked Questions

    Which drug class segment dominates the Inflammatory Bowel Disease Treatment Market?

    Based on drug class, the market is segmented into biologics, aminosalicyclates, corticosteroids, and others. The biologics segment held the largest Inflammatory Bowel Disease Treatment Market share in 2023 and is anticipated to register the highest CAGR during 2023–2031.

    Which disease indication segment dominates the Inflammatory Bowel Disease Treatment Market?

    Based on disease indication, the Inflammatory Bowel Disease Treatment Market is segmented into crohn's disease and ulcerative colitis. The crohn's disease segment is anticipated to hold a significant share by 2031.

    What was the estimated Inflammatory Bowel Disease Treatment Market size in 2023?

    The Inflammatory Bowel Disease Treatment Market was valued at US$ 24.05 billion in 2023.

    What are the growth estimates for the Inflammatory Bowel Disease Treatment Market till 2031?

    The Inflammatory Bowel Disease Treatment Market is expected to be valued at US$ 31.67 billion in 2031.

    Who are the major players in the Inflammatory Bowel Disease Treatment Market?

    The Inflammatory Bowel Disease Treatment Market has major market players, including AbbVie Inc, Takeda Pharmaceutical Company Limited, Pfizer Inc, Biogen, Novartis AG, Lilly, UCB S.A., CELLTRION INC., Merck & Co., Inc., and Johnson & Johnson Services, Inc.

    What factors drive the Inflammatory Bowel Disease Treatment Market?

    The key factors driving the Inflammatory Bowel Disease Treatment Market growth are the rising prevalence of crohn's disease and ulcerative colitis and increasing product launches over the projection period. Inflammatory Bowel Disease Treatment Market trends include the technological advancement in IBD treatment. Furthermore, the development of innovative treatments through continuing research as well as encouraging government initiatives are also expected to fuel the market growth.

    What is inflammatory bowel disease?

    Inflammatory bowel disease" (IBD) is a chronic inflammatory condition of the gastrointestinal tract, including Crohn's disease and ulcerative colitis. These conditions cause inflammation of the digestive tract lining, leading to symptoms like abdominal pain, diarrhea, fatigue, and weight loss. Treatment aims to reduce inflammation, manage symptoms, and prevent complications through medication, lifestyle changes, and sometimes surgery. Managing IBD typically requires ongoing medical care and monitoring to maintain remission and improve quality of life.

    Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    user

    I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

    DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
    user

    The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

    Yukihiko Adachi CEO, Deep Blue, LLC.

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Strategic Planning
    • Investment Justification
    • Identifying Emerging Markets
    • Enhancing Marketing Strategies
    • Boosting Operational Efficiency
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients

    The List of Companies - Inflammatory Bowel Disease Treatment Market

    1. AbbVie Inc
    2. Takeda Pharmaceutical Company Limited
    3. Pfizer Inc
    4. Biogen
    5. Novartis AG
    6. Lilly
    7. UCB S.A.
    8. CELLTRION INC.
    9. Merck & Co., Inc.
    10. Johnson & Johnson Services, Inc.
    11. Mindray Medical International Limited
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo